Life Sciences

Developing solutions that reduce cost, enhance collaboration and accelerate scientific discovery.

From R&D to manufacturing, we offer custom real estate strategies that create a competitive edge for your business.

 

The Life Sciences industry is undergoing an unprecedented transformation. Prompted by advances in technology, a dwindling supply of suitable lab space and the emergence of new competitors, life science companies are being forced to rethink their real estate strategies.

Cresa’s Life Sciences Practice Group provides occupier-only corporate real estate services to companies in the biotechnology and pharmaceutical industries. We help you stay cost-effective and flexible so you can focus on what matters most – your next discovery.

scientists looking at an equation

Leaders

Let us find someone near you with Life Sciences expertise

Find your local advisor

Latest Insights

orpik blog
Blog
August 24, 2020

How to Have Success in a Post-COVID Market

As companies look for guidance on how to take advantage of a softening market, there are a few things that can help lead to better outcomes. While some may seem basic, putting these ideas into practice is a key indicator of successful results.
duncan blog
Blog
August 5, 2020

Marketing Your Space with Video

To demonstrate the quality of your space, it is vital to properly market your office through diverse multimedia. Whether it’s for an upcoming sublease or sale, or just to demonstrate your company’s value to potential talent, a virtual tour video serves as an innovative and interactive asset.
Workplace 2.0: A New Paradigm Forced by Today's Challenges
Blog
November 19, 2021

Nonprofit Return to Office: The HR Perspective

COVID-19 has prompted the most notable workplace transformation of our time. As companies rethink how and where they work, HR departments are at the center of this evolution, crafting policies and developing guidance to keep their workforce healthy, productive and supported.
Greg Schiffman, CFO Absci
Blog
November 18, 2021

From Startup to IPO, Growth Mindset with Absci CFO

On this episode Blake welcomes Greg Schiffman, Chief Financial Officer for Absci, the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. Greg discusses his career journey, the exciting growth from startup to IPO, and how SW Washington and Portland are positioned well to become a biotech hub.